Zobrazeno 1 - 10
of 31
pro vyhledávání: '"V V, Altunin"'
Publikováno v:
Российский нейрохирургический журнал им. профессора А.Л. Поленова. 15:84-94
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::196b23e98dd1dd198c44314e41108712
https://doi.org/10.56618/2071-2693_2023_15_1_84
https://doi.org/10.56618/2071-2693_2023_15_1_84
Publikováno v:
Вопросы современной педиатрии, Vol 14, Iss 6, Pp 638-644 (2016)
Cardiovascular disease (CVD) is one of the main reasons for the high mortality rate in the world. In recent years, the importance of vascular lesions of the heart and brain in the structure of causes of death among adolescents has increased. The main
Externí odkaz:
https://doaj.org/article/ac5a3bbd4f01419f855920546abd1329
Autor:
S. A. Nemkova, O. I. Maslova, N. N. Zavadenko, T. Li, N. N. Volodin, V. А. Dorovskikh, G. A. Karkashadze, A. M. Mamed''yarov, V. V. Altunin, E. A. Abashidze, O. V. Kozhevnikov, Yu. E. Nesterovskii
Publikováno v:
Педиатрическая фармакология, Vol 12, Iss 2, Pp 180-189 (2015)
The article is devoted to the actual problem of modern pediatrics and neurology ― a comprehensive diagnosis and correction of sleep disorders in children. Detail the features of the clinical manifestations of sleep disorders in childhood (insomnia
Externí odkaz:
https://doaj.org/article/5e885a18695045ecb23d808bc8963a6d
Autor:
I. V. Davydova, L. S. Namazova-Baranova, V. V. Altunin, O. V. Kozhevnikova, E. P. Zimina, E. V. Churbanova, E. V. Pavlukova, E. Yu. Basargina
Publikováno v:
Педиатрическая фармакология, Vol 11, Iss 6, Pp 42-51 (2014)
Background. Capabilities of assessing functional condition of the respiratory system in young children, including patients with bronchopulmonary dysplasia, are extremely limited, as little children do not cooperate with doctors in the course of diagn
Externí odkaz:
https://doaj.org/article/4836299b197646858aa6ea455fa2d2e3
Autor:
N. D. Vashakmadze, L. S. Namazova-Baranova, A. K. Gevorkyan, V. V. Altunin, L. M. Kuzenkova, E. G. Chernavina, M. A. Babaykina, T. V. Podkletnova, O. V. Kozhevnikova
Publikováno v:
Педиатрическая фармакология, Vol 10, Iss 6, Pp 76-81 (2013)
17 children received cardiorespiratory monitoring in order to evaluate spread and dynamics of changes in the primary obstructive sleep apnea syndrome (OSAS) parameters at type II mucopolysaccharidosis. Mild OSAS [apnea/hypopnea index (AHI) – 1.5-5]
Externí odkaz:
https://doaj.org/article/220644e28d7a4aebb6c909983333d07b
Publikováno v:
Педиатрическая фармакология, Vol 10, Iss 5, Pp 90-93 (2013)
When prescribing mucolytic therapy for bronchopulmonary diseases to infants, it is necessary to consider not only peculiarities of a small child’s respiratory tract, but also action of mucolytic drugs. The authors exemplify their data on efficacy a
Externí odkaz:
https://doaj.org/article/c1d7b8e1beb14aaf919563f24a8a9ba5
Publikováno v:
Педиатрическая фармакология, Vol 10, Iss 2, Pp 87-91 (2013)
At present ca. 25% of children have sleep disorders. The main method of diagnosing sleep disorders is polysomnography. The article presents the analysis of night sleep study results in children with various pathologies. The study involved 103 childre
Externí odkaz:
https://doaj.org/article/c98d47c89a8a408ab961fc9a4600709b
Autor:
A. A. Baranov, I. V. Davydova, T. V. Turti, L. S. Namazova-Baranova, V. V. Altunin, E. P. Zimina, E. V. Pavlyukova
Publikováno v:
Педиатрическая фармакология, Vol 9, Iss 6, Pp 48-52 (2012)
Children with bronchopulmonary dysplasia belong to the risk group of severe respiratory-syncytial viral infection (RSV). World experience and authors' own clinical data show that seasonal immunoprophylaxis of RSV infection's severe course by palivizu
Externí odkaz:
https://doaj.org/article/8fd33db4883b4ea8a854c0bafd9ccc15
Publikováno v:
Педиатрическая фармакология, Vol 9, Iss 5, Pp 42-48 (2012)
Mucolytic drugs, particularly, direct action mucolytics with acetylcysteine derivatives among them, are included in the complex therapy of the bronchopulmonary dysplasia exacerbations. However, data on application effectiveness and safety of such a t
Externí odkaz:
https://doaj.org/article/c0f1941bd4ca422498db2ce9fd0cde74
EXPERIENCE IN THE USE OF ACETYLCYSTEINE IN THE TREATMENT OF RESPIRATORY INFECTIONS IN YOUNG CHILDREN
Autor:
I. V. Davydova, T. V. Tourte, L. S. Namazova-Baranova, A. Yu. Simonova, L. R. Tarasova, V. V. Altunin
Publikováno v:
Педиатрическая фармакология, Vol 9, Iss 2, Pp 67-73 (2012)
Treatment of respiratory infections in early childhood requires extensive use of direct action mucolytic drugs, which include derivatives of acetylcysteine. However, data on efficacy and safety of acetylcysteine in the treatment of both acute and chr
Externí odkaz:
https://doaj.org/article/62531225eda642428d488c7004eaa2e2